Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neovascularization, Physiologic | 4 | 2019 | 80 | 2.120 |
Why?
|
| Exosomes | 5 | 2021 | 126 | 1.930 |
Why?
|
| MicroRNAs | 6 | 2021 | 518 | 1.570 |
Why?
|
| Myocardial Ischemia | 2 | 2018 | 83 | 1.040 |
Why?
|
| Adipose Tissue | 2 | 2017 | 182 | 0.900 |
Why?
|
| Stem Cells | 4 | 2021 | 152 | 0.880 |
Why?
|
| Ischemia | 2 | 2020 | 47 | 0.750 |
Why?
|
| Repressor Proteins | 3 | 2013 | 273 | 0.690 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2016 | 140 | 0.680 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2016 | 91 | 0.680 |
Why?
|
| Carotid Arteries | 2 | 2016 | 36 | 0.610 |
Why?
|
| Nerve Tissue Proteins | 2 | 2016 | 386 | 0.610 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 47 | 0.600 |
Why?
|
| Heart | 2 | 2018 | 184 | 0.600 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 247 | 0.580 |
Why?
|
| Endothelial Cells | 2 | 2021 | 329 | 0.520 |
Why?
|
| Dermatitis, Irritant | 1 | 2016 | 1 | 0.520 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2016 | 5 | 0.510 |
Why?
|
| Diclofenac | 1 | 2016 | 5 | 0.510 |
Why?
|
| G1 Phase | 2 | 2016 | 31 | 0.510 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 316 | 0.500 |
Why?
|
| Menthol | 1 | 2016 | 23 | 0.500 |
Why?
|
| Wound Healing | 1 | 2017 | 88 | 0.490 |
Why?
|
| Adult Stem Cells | 1 | 2016 | 12 | 0.490 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2016 | 32 | 0.490 |
Why?
|
| S Phase | 1 | 2016 | 36 | 0.480 |
Why?
|
| Skin | 1 | 2016 | 187 | 0.460 |
Why?
|
| Brain Ischemia | 1 | 2017 | 189 | 0.450 |
Why?
|
| Adipocytes | 2 | 2013 | 60 | 0.450 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 150 | 0.450 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 140 | 0.440 |
Why?
|
| Adipogenesis | 1 | 2013 | 14 | 0.410 |
Why?
|
| Mitochondria | 3 | 2013 | 523 | 0.410 |
Why?
|
| Animals | 12 | 2021 | 16992 | 0.400 |
Why?
|
| Transcription Factors | 1 | 2016 | 735 | 0.340 |
Why?
|
| Cells, Cultured | 6 | 2016 | 1621 | 0.330 |
Why?
|
| Hindlimb | 2 | 2020 | 32 | 0.310 |
Why?
|
| Rats | 6 | 2017 | 3735 | 0.280 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2021 | 88 | 0.280 |
Why?
|
| Stem Cell Transplantation | 2 | 2018 | 39 | 0.270 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1070 | 0.250 |
Why?
|
| Cell Movement | 3 | 2019 | 655 | 0.250 |
Why?
|
| Mice | 4 | 2021 | 6644 | 0.250 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2019 | 1766 | 0.230 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2006 | 50 | 0.230 |
Why?
|
| Obesity | 1 | 2013 | 1151 | 0.230 |
Why?
|
| Up-Regulation | 3 | 2016 | 536 | 0.200 |
Why?
|
| Cell Line | 2 | 2019 | 1410 | 0.190 |
Why?
|
| Receptors, Immunologic | 2 | 2016 | 73 | 0.180 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2016 | 100 | 0.170 |
Why?
|
| Humans | 13 | 2018 | 43102 | 0.160 |
Why?
|
| Reactive Oxygen Species | 2 | 2013 | 532 | 0.160 |
Why?
|
| Angiogenic Proteins | 1 | 2019 | 7 | 0.160 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 53 | 0.150 |
Why?
|
| Gene Silencing | 2 | 2012 | 154 | 0.150 |
Why?
|
| Cell Differentiation | 2 | 2013 | 638 | 0.150 |
Why?
|
| Male | 6 | 2019 | 23409 | 0.150 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2018 | 10 | 0.150 |
Why?
|
| Recovery of Function | 1 | 2019 | 107 | 0.150 |
Why?
|
| Caspase 3 | 2 | 2016 | 227 | 0.130 |
Why?
|
| Antipruritics | 1 | 2016 | 3 | 0.130 |
Why?
|
| Administration, Cutaneous | 1 | 2016 | 48 | 0.130 |
Why?
|
| Gels | 1 | 2016 | 45 | 0.130 |
Why?
|
| Drug Combinations | 1 | 2016 | 104 | 0.120 |
Why?
|
| E2F1 Transcription Factor | 1 | 2016 | 22 | 0.120 |
Why?
|
| Cell-Derived Microparticles | 1 | 2016 | 8 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2016 | 23 | 0.120 |
Why?
|
| Microvessels | 1 | 2016 | 31 | 0.120 |
Why?
|
| Macrophages | 1 | 2020 | 529 | 0.120 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 83 | 0.120 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2015 | 25 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 146 | 0.120 |
Why?
|
| Cytokines | 1 | 2019 | 678 | 0.110 |
Why?
|
| Serum Albumin, Bovine | 1 | 2015 | 49 | 0.110 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2015 | 34 | 0.110 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 259 | 0.110 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2006 | 28 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 139 | 0.110 |
Why?
|
| Apoptosis | 2 | 2016 | 1568 | 0.110 |
Why?
|
| Endocytosis | 1 | 2015 | 118 | 0.110 |
Why?
|
| Mice, Nude | 1 | 2016 | 408 | 0.110 |
Why?
|
| Endometriosis | 1 | 2016 | 83 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 1869 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 1596 | 0.100 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1455 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 561 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2016 | 561 | 0.090 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 436 | 0.090 |
Why?
|
| 3T3-L1 Cells | 1 | 2012 | 18 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 161 | 0.090 |
Why?
|
| Oligonucleotides | 1 | 2012 | 49 | 0.090 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 167 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 160 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2013 | 456 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 300 | 0.090 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 224 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2016 | 1271 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2019 | 2157 | 0.090 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 191 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 2853 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2009 | 1 | 0.080 |
Why?
|
| Follicular Fluid | 1 | 2009 | 5 | 0.080 |
Why?
|
| Ovulation Induction | 1 | 2009 | 5 | 0.080 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2009 | 25 | 0.070 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 2006 | 4 | 0.070 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2009 | 39 | 0.070 |
Why?
|
| Carcinoma, Papillary | 1 | 2008 | 15 | 0.070 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2008 | 20 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2008 | 346 | 0.060 |
Why?
|
| Young Adult | 1 | 2016 | 5080 | 0.060 |
Why?
|
| Adolescent | 1 | 2016 | 6081 | 0.060 |
Why?
|
| Caveolins | 1 | 2004 | 9 | 0.050 |
Why?
|
| Serine | 1 | 2004 | 79 | 0.050 |
Why?
|
| Aged | 1 | 2016 | 8214 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 415 | 0.050 |
Why?
|
| Adult | 2 | 2016 | 13872 | 0.050 |
Why?
|
| Cholesterol | 1 | 2004 | 232 | 0.050 |
Why?
|
| Female | 4 | 2016 | 24698 | 0.050 |
Why?
|
| Middle Aged | 1 | 2016 | 12222 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 1019 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2016 | 12 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2016 | 55 | 0.030 |
Why?
|
| Culture Media | 1 | 2016 | 96 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 2015 | 12 | 0.030 |
Why?
|
| Clathrin | 1 | 2015 | 21 | 0.030 |
Why?
|
| Lysosomes | 1 | 2015 | 86 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 97 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 114 | 0.030 |
Why?
|
| Tissue Preservation | 1 | 2013 | 7 | 0.020 |
Why?
|
| Rats, Transgenic | 1 | 2013 | 34 | 0.020 |
Why?
|
| Protein Stability | 1 | 2013 | 48 | 0.020 |
Why?
|
| Cryopreservation | 1 | 2013 | 39 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2015 | 434 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2013 | 115 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 416 | 0.020 |
Why?
|
| Temperature | 1 | 2013 | 313 | 0.020 |
Why?
|
| Embryo Transfer | 1 | 2009 | 33 | 0.020 |
Why?
|
| Fertilization in Vitro | 1 | 2009 | 57 | 0.020 |
Why?
|
| Staurosporine | 1 | 2008 | 38 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 1857 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2008 | 62 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2008 | 34 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2008 | 165 | 0.020 |
Why?
|
| Ovary | 1 | 2008 | 113 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 256 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 518 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 458 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2008 | 883 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2008 | 307 | 0.010 |
Why?
|
| Cell Survival | 1 | 2008 | 945 | 0.010 |
Why?
|
| Caveolae | 1 | 2004 | 10 | 0.010 |
Why?
|
| Caveolin 1 | 1 | 2004 | 33 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2004 | 25 | 0.010 |
Why?
|
| Tyrosine | 1 | 2004 | 120 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 186 | 0.010 |
Why?
|
| Biological Transport | 1 | 2004 | 204 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2004 | 109 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2004 | 124 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 968 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 986 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 2676 | 0.010 |
Why?
|
| Peptides | 1 | 2004 | 372 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 1082 | 0.010 |
Why?
|